Iambic and Takeda have announced a multi-year technology and discovery collaboration agreement to advance the AI-driven design and development of high-priority small molecule drug...
Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, announced raising over $100 million in...